Ignite Creation Date:
2025-12-24 @ 7:17 PM
Ignite Modification Date:
2025-12-29 @ 1:06 AM
Study NCT ID:
NCT02114203
Status:
COMPLETED
Last Update Posted:
2017-12-14
First Post:
2014-04-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Study Of PF-04447943, Co-Administered With And Without Hydroxyurea, In Subjects With Stable Sickle Cell Disease
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-07
First Submit QC Date:
None
Study First Post Date:
2014-04-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-07-17
Results First Submit QC Date:
None
Results First Post Date:
2017-12-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-17
Last Update Post Date:
2017-12-14
Last Update Post Date Type:
ACTUAL